Nifedipine does not induce but rather prevents apoptosis in cardiomyocytes

European Journal of Pharmacology

Volumn 388, Issue 3, 2000, Pages 209-217

  Rabkin, Simon W ^a   Kong, Jennifer Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Ca2+; Cardiomyocyte; Nifedipine

Indexed keywords

CALCIUM; CALCIUM ANTAGONIST; DNA FRAGMENT; FLUORESCEIN DIACETATE; NIFEDIPINE; PHOSPHATIDYLINOSITOL; PROPIDIUM IODIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM ANTAGONISM; CELL VIABILITY; CHICK EMBRYO; CONCENTRATION RESPONSE; DNA DETERMINATION; DRUG EFFECT; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR CALCIUM; FLUORESCENCE ACTIVATED CELL SORTER; HEART FAILURE; HEART MUSCLE CELL; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CHICK EMBRYO; DEPRESSION, CHEMICAL; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MYOCARDIUM; NIFEDIPINE;

EID: 0033963109     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00880-8     Document Type: Article

References (51)

1. +2 requiring mechanism(s). J. Biol. Chem. 265:1990;17323-17333.
2. 2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells. J. Lipid Res. 38:1997;2049-2061.
3. Balakumaran A., Campbell G.A., Moslen M.T. Calcium channel blockers induce thymic apoptosis in vivo in rats. Toxicol. Appl. Pharmacol. 139:1996;122-127.
4. Bansal N., Houle A.G., Malnykovych G. Dexamethasone-induced killing of neoplastic cells of lymphoid derivation: lack of early calcium involvement. J. Cell Physiol. 143:1990;105-109.
5. Bonfoco E., Krainic D., Ankarcrona M., Nicotera P., Ipton S. Apoptosis and necrosis: two distinct events induced, respectively by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7162-7166.
6. Brown G.R., Fraser D.G., Castle J.A., Gausreault P.D.R., Freidman P.A. Nifedipine serum concentrations following sublingual and oral doses. Int. J. Clin. Pharm. 24:1986;283-286.
7. Darzynkiewicz Z., Juan G., Gorczyca W., Murakami T., Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 27:1977;1-20.
8. DeBlois D., Tea B.S., Than V.D., Tremblay J., Hamet P. Smooth muscle apoptosis during vascular regression in hypertensive rats. Hypertension. 29:1997;340-349.
9. Dhalla N.S. Involvement of membrane systems in heart failure due to intracellular calcium overload and deficiency. J. Mol. Cell. Cardiol. 8:1976;661-667.
10. Dowd D.R. Calcium regulation of apoptosis. Adv. Second Messenger Phosphoprotein Res. 30:1995;255-280.
11. Dowd D., MacDonals P., Komm B., Haussler M.R., Miessfeld R.L. Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol. Endocrinol. 6:1992;1843-1848.
12. El Alaoui S., Mian S., Lawry J., Quash G., Griffin M. Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis). FEBS Lett. 311:1992;174-178.
13. Eguchi Y., Ewert D.L., Tsujimoto Y. Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissue including lymphoid and neuronal organs in adult and embryo. Nucleic Acids Res. 220:1992;41187-41192.
14. Enokido Y., Hatanaka H. Apoptotic cell death occurs in hippocampal neurons cultured in a high oxygen atmosphere. Neuroscience. 57:1993;965-972.
15. Escargueil-Blanc I., Meilhac O., Pieraggi M.T., Arnal J.F., Salvayrem R., Negre-Salvayre A. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. Arterioscler., Thromb., Vasc. Biol. 17:1997;331-339.
16. Fitzpatrick D.B., Karmazyn M. Comparative effects of calcium channel blocking agents and varying extracellular calcium concentration on hypoxia/reoxygenation and ischemia/reperfusion-induced cardiac injury. J. Pharmacol. Exp. Ther. 228:1984;761-768.
17. Frey T. Correlated flow cytometric analysis of terminal events in apoptosis reveals the absence of some changes in some model systems. Cytometry. 28:1997;253-263.
18. Froelich-Ammon S.J., Osheroff N. Topoisomerase poisons, harnessing the dark side of enzyme mechanisms. J. Biol. Chem. 270:1995;21429-21432.
19. Galli C., Meucci O., Scorziello A., Werge T.M., Calissano P., Schettini G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J. Neurosci. 15:1995;1172-1179.
20. Holmes F.A., Lopez A., Mavligit G., Fraschini G., Frye D., Hortobagyi G.N. Secondary drug resistance in breast cancer: failure to reverse with oral nifedipine. Int. J. Cancer. 73:1997;184-186.
21. Itoh G., Tamura J., Suzuki M., Suzuki Y., Ikeda H., Koike M., Nomura M., Jie T., Ito K. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am. J. Pathol. 146:1995;1325-1331.
22. Jimenez E., del Nido P., Sarin M., Nakamura H., Feinberg H., Levitsky S. Effects of low extracellular calcium on cytosolic calcium and ischemic contracture. J. Surg. Res. 49:1990;252-255.
23. Kluck R.M., McDougall C.A., Harmon B.V., Halliday J.W. Calcium chelators induce apoptosis - evidence that raised intracellular ionised calcium is not essential for apoptosis. Biochim. Biophys. Acta. 1223:1994;247-254.
24. Kondo S., Yin D., Morimura T., Kubo H., Nakatsu S., Takeuchi J. Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells. Br. J. Cancer. 71:1995;282-289.
25. Kong J.Y., Rabkin S.W. Thapsigargin enhances camptothecin-induced apoptosis in cardiomyocytes. Pharmacol. Toxicol. 89:1999;212-220.
26. 2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate. 13:1988;103-117.
27. Leenen F.H.H. Dihydropyridine calcium antagonists and sympathetic activity: relevance to cardiovascular morbidity and mortality. Epstein M. Calcium Antagonists in Clinical Medicine. 2nd Edition:1998;527-555. Chap. 28.
28. Leist M., Gantner F., Bohlinger Germann P.G., Tiegs G.A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-a requires transcriptional arrest. J. Immunol. 153:1994;1778-1788.
29. Lennon S.V., Kilfeather S.A., Hallett M.B., Campbell A.K., Cotter T.G. Elevations in cytosolic free Ca+2 are not required to trigger apoptosis in human leukaemia cells. Clin. Exp. Immunol. 87:1992;465-471.
30. Li L.H., Wine R.N., Miller D.S., Reece J.M., Smith M., Chapin R.E. Protection against methoxyacetic-acid-induced spermatocyte apoptosis with calcium channel blockers in cultured rat seminiferous tubules: possible mechanisms. Toxicol. Appl. Pharmacol. 144:1997;105-119.
31. Lin X.S., Denmeade S.R., Cisek L., Isaacs J.T. Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin. Prostate. 33:1997;201-207.
32. Lockshin R., Zakeri Z. Programmed cell death: early changes in metamorphosing cells. Biochem. Cell Biol. 72:1994;589-596.
33. Loveland B.E., Johns T.G., Mackay I.R., Vaillant F., Wang Z.X., Hertzog P.J. Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem. Int. 27:1992;501-510.
34. MacLellan W.R., Schneider M.D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ. Res. 81:1997;137-144.
35. McConkey D.J., Orrenius S. The role of calcium in the regulation of apoptosis. J. Leukocyte Biol. 59:1996;775-783.
36. Messerli F.H., Grossman E. The calcium antagonist controversy: a posthumous commentary. Am. J. Cardiol. 82(9B):1998;35R-39R.
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 5:1983;55-63.
38. Myers M.G., Raemsch K.D. Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule. J. Cardiovasc. Pharmacol. 10:1987;S76-S78. Suppl.
39. Narula J., Haider N., Virmani R., Disalvo T.G., Kolodgie F.D., Hajjar R.J., Schmidt U., Semigran M.J., Dec G.W., Khaw B.A. Apoptosis in myocytes in end stage heart failure. New Engl. J. Med. 335:1996;1182-1189.
40. Nicotera P., Orrenius S. The role of calcium in apoptosis. Cell Calcium. 23:1998;173-180.
41. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., Quaini E., Diloreto C., Beltrami C.A., Krajewski S., Reed J.C., Anversa P. Apoptosis in the failing human heart. New Engl. J. Med. 336:1997;1131-1141.
42. Pahor M., Guralnik J.M., Ferrucci L., Corti M.C., Salive M.E., Cerhan J.R., Wallace R.B., Havlik R.J. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 348:1996;493-497.
43. Pisani A., Calabresi P., Tozzi A., D'Angelo V., Bernardi G. L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons. Stroke. 29:1998;196-201.
44. 45Ca-efflux in embryonic heart and its modification by caffeine and ryanodine. J. Dev. Physiol. 18:1992;285-293.
45. Rabkin S.W. Lisinopril increases the recovery during reoxygenation and resistance to oxidative damage in cardiomyocytes. Eur. J. Pharmacol. 238:1993;81-88.
46. Rabkin S.W., Kong J. Norepinephrine produced cardiomyocyte death through apoptosis (abst.). Circulation. 94:1996;I65.
47. Trump B.F., Berezesky I.K., Chang S.H., Phelps P.C. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol. Pathol. 25:1997;82-88.
48. Veinot J.P., Gattinger D.A., Fliss H. Early apoptosis in human myocardial infarction human pathology. Hum. Pathol. 28:1997;485-492.
49. Ver Donck L., Borgers M., Verdonck F. Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc. Res. 27:1993;349-357.
50. Wyllie A.H. Apoptosis and the regulation of cell number in normal and neoplastic tissues: an overview. Cancer and Metastasis. 11:1992;95-103.
51. Zaugg C.E., Kojima S., Wu S.T., Wikman-Coffelt J., Parmley W.W., Buser P.T. Intracellular calcium transients underlying interval-force relationship in whole rat hearts: effects of calcium antagonists. Cardiovasc. Res. 30:1995;212-221.